此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Bariatric Surgery in Children. (BASIC)

2021年8月25日 更新者:Maastricht University Medical Center

The BASIC Trial. Morbid Obesity in Children and Adolescents: a Prospective Randomised Trial of Conservative Treatment Versus Surgery

Rationale:

In the Western world overweight and obesity is an increasing problem both in adults and in children. In youth, it is associated with early death and a number of co-morbidities including metabolic and endocrine changes, increased inflammatory status, cardiovascular abnormalities, nonalcoholic fatty liver disease, and impaired quality of life.

The standard treatment for morbid obesity in children is by combined life style interventions. However, the medium and long term effects of dietetic interventions, behaviour therapy and medication is relatively poor. In adults bariatric surgery shows good results with up to 30% weight reduction in 3 years. The preliminary results in youth are similar, but surgery in this age group is relatively uncommon. In the Netherlands surgery in this age group is only allowed in clinical trials, until the benefits and risks have been established. (National Health Authorities)

Objective:

To determine if surgery gives a superior weight and body mass index (BMI) reduction than combined life style interventions in adolescents with morbid obesity and to assess its effect on obesity associated co-morbidity.

Study design:

Prospective randomised interventional study.

Study population:

Morbidly obese children, aged 14 - 16 years, with sex and age adjusted BMI >40 kg/m2 or >35 kg/m2 with co-morbidity.

Intervention:

Bariatric surgery by laparoscopic adjustable gastric band (LAGB) or combined life style interventions

Main study parameters/endpoints:

Primary endpoints: weight loss, loss of excess weight, loss of excess BMI. Secondary endpoints: Body composition, pubertal development, metabolic and endocrine changes, inflammatory status, cardiovascular abnormalities, non-alcoholic steatohepatitis, brain development, quality of life, and behaviour changes. The potential complications of surgery are monitored.

研究概览

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Limburg
      • Maastricht、Limburg、荷兰、6202ZA
        • Maastricht University Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

14年 至 16年 (孩子)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Aged 14 to 16
  • Age and sex adjusted BMI >40 kg/m2 or >35 kg/m2 with associated co-morbidity.

    * Associated co-morbidity includes: glucose intolerance, type 2 diabetes, hypertension, pseudotumor cerebri, acanthosis nigricans, obstructive sleep apnoea syndrome, depression, arthropathies, non-alcoholic steatohepatitis and dyslipidemia.

  • > 1 year multidisciplinary organized weight reducing attempts with less than 5% weight loss
  • Demonstrate decisional capacity

Exclusion Criteria:

  • Psychologically not suitable
  • Pre-menarche or bone age <15 years in boys
  • Obesity associated to other disorders such as hypothyroidism
  • Syndromal disorders such as Prader-Willi syndrome
  • Severe cardiorespiratory impairment (ASA class 3 or higher)
  • Insufficiently fluid in the Dutch language
  • Unwillingness to adhere to follow-up programmes

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
有源比较器:控制组
Control group will receive standard therapy consisting of combined lifestyle interventions.
实验性的:Laparoscopic adjustable gastric band
Laparoscopic gastric band placement. Combined lifestyle interventions will continue after surgery.
Control group will receive standard therapy consisting of combined lifestyle interventions.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Weight
大体时间:6 months
Weight loss, excess weight loss and loss of excess BMI.
6 months
Weight
大体时间:12 months
Weight loss, excess weight loss and loss of excess BMI.
12 months
Weight
大体时间:24 months
Weight loss, excess weight loss and loss of excess BMI.
24 months
Weight
大体时间:36 months
Weight loss, excess weight loss and loss of excess BMI.
36 months

次要结果测量

结果测量
措施说明
大体时间
Body composition
大体时间:12 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
12 months
Pubertal development
大体时间:6 months
Follow-up of hormonal status and Tanner stages.
6 months
Metabolic and endocrine changes
大体时间:6 months
6 months
Inflammatory status
大体时间:6 months
Measurement of serum inflammatory markers.
6 months
Cardiovascular abnormalities
大体时间:6 months
6 months
Non-alcoholic fatty liver disease
大体时间:6 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
6 months
Quality of life changes
大体时间:6 months
6 months
Behaviour changes
大体时间:6 months
Measuring impulsivity and positive reward dominance with a computer task.
6 months
Operative complications
大体时间:up to 36 months
Early and late complications are being monitored
up to 36 months
Effects on sleep architecture
大体时间:6 months
6 months
Brain development
大体时间:6 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
6 months
Body composition
大体时间:24 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
24 months
Body composition
大体时间:36 months
Next to anthropometric measurements, bone mineral content, bone density, lean bodymass and fat percentage will be assessed.
36 months
Pubertal development
大体时间:12 months
Follow-up of hormonal status and Tanner stages.
12 months
Pubertal development
大体时间:24 months
Follow-up of hormonal status and Tanner stages.
24 months
Pubertal development
大体时间:36 months
Follow-up of hormonal status and Tanner stages.
36 months
Metabolic and endocrine changes
大体时间:12 months
12 months
Metabolic and endocrine changes
大体时间:24 months
24 months
Metabolic and endocrine changes
大体时间:36 months
36 months
Inflammatory status
大体时间:12 months
Measurement of serum inflammatory markers.
12 months
Inflammatory status
大体时间:24 months
Measurement of serum inflammatory markers.
24 months
Inflammatory status
大体时间:36 months
Measurement of serum inflammatory markers.
36 months
Cardiovascular abnormalities
大体时间:12 months
12 months
Cardiovascular abnormalities
大体时间:24 months
24 months
Cardiovascular abnormalities
大体时间:36 months
36 months
Non-alcoholic fatty liver disease
大体时间:12 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
12 months
Non-alcoholic fatty liver disease
大体时间:24 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
24 months
Non-alcoholic fatty liver disease
大体时间:36 months
Next to an ultrasound of the liver, serum levels of ALT, AST, ALP and GGT are measured. CCL-2 is used as a surrogate marker to assess liver disease.
36 months
Quality of life changes
大体时间:12 months
12 months
Quality of life changes
大体时间:24 months
24 months
Quality of life changes
大体时间:36 months
36 months
Effects on sleep architecture
大体时间:12 months
12 months
Effects on sleep architecture
大体时间:24 months
24 months
Effects on sleep architecture
大体时间:36 months
36 months
Behaviour changes
大体时间:12 months
Measuring impulsivity and positive reward dominance with a computer task.
12 months
Behaviour changes
大体时间:24 months
Measuring impulsivity and positive reward dominance with a computer task.
24 months
Behaviour changes
大体时间:36 months
Measuring impulsivity and positive reward dominance with a computer task.
36 months
Brain development
大体时间:12 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
12 months
Brain development
大体时间:24 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
24 months
Brain development
大体时间:36 months
If extra sponsorship can be gained, we will use fMRI and MEG in a subgroup to measure blood oxygen level-dependent (BOLD) brain response to food stimuli.
36 months
Physical activity
大体时间:6 months
Assessment of physical activity using a questionnaire and an accelerometer.
6 months
Physical activity
大体时间:12 months
Assessment of physical activity using a questionnaire and an accelerometer.
12 months
Physical activity
大体时间:24
Assessment of physical activity using a questionnaire and an accelerometer.
24
Physical activity
大体时间:36 months
Assessment of physical activity using a questionnaire and an accelerometer.
36 months
Behavior towards food
大体时间:6 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
6 months
Behavior towards food
大体时间:12 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
12 months
Behavior towards food
大体时间:24 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
24 months
Behavior towards food
大体时间:36 months
Behavior towards food is assessed by questionnaires and a computerized model for wanting and liking of food.
36 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:LWE van Heurn, Professor、Maastricht University Medical Center
  • 首席研究员:Yvonne Roebroek, PhD Student、Maastricht University Medical Center
  • 首席研究员:Givan F Paulus, PhD Student、Spaarne Gasthuis, Haarlem

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2011年12月1日

初级完成 (预期的)

2022年12月1日

研究完成 (预期的)

2022年12月1日

研究注册日期

首次提交

2010年7月22日

首先提交符合 QC 标准的

2010年7月29日

首次发布 (估计)

2010年7月30日

研究记录更新

最后更新发布 (实际的)

2021年8月26日

上次提交的符合 QC 标准的更新

2021年8月25日

最后验证

2021年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • NL26279.068.09

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅